Neuropsychiatric Drugs Market Forecast Highlights Growth Opportunities Fueled by Novel Antipsychotics and R&D Investments

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on "Global Neuropsychiatric Drugs Market- By Trends, Industry Competition Analysis, Revenue and Forecast to 2034."

The Neuropsychiatric Drugs Market is expected to grow at a 5.0 % CAGR during the forecast period for 2025-2034.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1170

Neuropsychiatric disorders represent a broad category of medical conditions that intersect the disciplines of neurology and psychiatry, stemming from functional abnormalities within the brain. These disorders are particularly prevalent among pediatric and adolescent populations. While a range of pharmaceutical therapies is available for various stages of neuropsychiatric conditions, a considerable number of these treatments lack extensive clinical evaluation in children.

The global market for neuropsychiatric drugs is projected to witness significant growth over the forecast period. This expansion is driven by the high global prevalence of these disorders, the growing demand for cost-effective treatment alternatives, the continuous expansion of drug development pipelines, advancements in innovative therapeutic approaches, and intensified research and development initiatives aimed at discovering new drug candidates.

According to data from the World Health Organization (WHO), depression is among the leading causes of disability worldwide, impacting approximately 264 million people. The increasing incidence of depression and other related mental health conditions is expected to generate substantial opportunities for market growth in the years ahead.

Nevertheless, market expansion may be challenged by factors such as the necessity for prolonged treatment regimens and the occurrence of adverse side effects-such as blurred vision and insomnia-associated with neuropsychiatric medications, which may limit broader adoption.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Regionally, North America is projected to maintain the largest market share throughout the forecast period (2020-2030), followed by Europe. This dominance is attributed to heightened mental health awareness, a well-developed healthcare infrastructure, and substantial investments in research and development aimed at advancing novel treatments for neuropsychiatric disorders.

Major market players operating in the neuropsychiatric drugs market include Novartis (Switzerland), Pfizer (US), Otsuka (Japan), Allergan (Ireland), Eli Lilly (US), Sunovion (US), AstraZeneca (UK), Actavis Laboratories (US), Johnson & Johnson (US), Bristol Myers (US), Sage Therapeutics (US), BlackThorn Therapeutics (US), H. Lundbeck A/S (Denmark), Takeda (Japan), Cerevel Therapeutics, LLC (US) among others.

Some of the key developments in the market:
• In September 2021, Otsuka Pharmaceutical (Japan) and Sunovion (US), a subsidiary of Sumitomo, collaborated to develop and commercialize four clinical-stage neuropsychiatric compounds (ulotaront, non-racemic ratio of amisulpride enantiomers, SEP-378614, and SEP-380135). These four compounds are designed to treat psychiatric diseases.
• In June 2021, Eli Lilly Alzheimer's drug received breakthrough status from the FDA. The company has plans to submit a biologics license application (BLA) for donanemab under the accelerated approval pathway later this year based on data from TRAILBLAZER-ALZ.
• In March 2019, Novartis (Switzerland) received FDA approval for Mayzent (siponimod), the first oral drug to treat relapsing forms of multiple sclerosis (RMS).

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1170

Market Segments
Global Neuropsychiatric Drugs Market, by Drug Type, 2020-2030 (Value US$ Mn)
• Typical Antipsychotics
o Prochlorperazine
o Haloperidol
o Others
• Atypical Antipsychotics
o Aripiprazole
o Asenapine
o Cariprazine
o Clozapine
o Lurasidone
o Olanzapine
o Risperidone
o Others
Global Neuropsychiatric Drugs Market, by Indication, 2020-2030 (Value US$ Mn)
• Schizophrenia
• Bipolar Disorder
• Psychotic Depression
• Others
Global Neuropsychiatric Drugs Market, by Route of Administration, 2020-2030 (Value US$ Mn)
• Oral
• Parenteral
Global Neuropsychiatric Drugs Market, by Region, 2020-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Neuropsychiatric Drugs Market, by Country, 2020-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Neuropsychiatric Drugs Market, by Country, 2020-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Neuropsychiatric Drugs Market, by Country, 2020-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Neuropsychiatric Drugs Market, by Country, 2020-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Neuropsychiatric Drugs Market, by Country, 2020-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
• To receive a comprehensive analysis of the prospects for the global neuropsychiatric drugs market
• To receive an industry overview and future trends of the neuropsychiatric drugs market
• To analyze the neuropsychiatric drugs market drivers and challenges
• To get information on the neuropsychiatric drugs market value (US$ Mn) forecast to 2030
• Significant investments, mergers & acquisitions in the neuropsychiatric drugs market industry

Read Overview Report- https://www.insightaceanalytic.com/report/global-neuropsychiatric-drugs-market-/1170

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.